EP4225311 - TREATMENT OF SKIN DISEASES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.07.2023 Database last updated on 03.09.2024 | |
Former | The international publication has been made Status updated on 16.04.2022 | Most recent event Tooltip | 08.12.2023 | Change: Validation states | published on 10.01.2024 [2024/02] | 08.12.2023 | Change - extension states | published on 10.01.2024 [2024/02] | Applicant(s) | For all designated states Ichilov Tech Ltd. 6 Weizmann Street 6423906 Tel-Aviv / IL | [2023/33] | Inventor(s) | 01 /
SPRECHER, Eli 5320025 Givatayim / IL | 02 /
SARIG, Ofer 3009500 Ramat-Yishai / IL | [2023/33] | Representative(s) | Robba, Pierpaolo Interpatent S.R.L. Via Caboto, 35 10129 Torino / IT | [2023/33] | Application number, filing date | 21877136.8 | 05.10.2021 | [2023/33] | WO2021IL51197 | Priority number, date | US202063087353P | 05.10.2020 Original published format: US 202063087353 P | [2023/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022074649 | Date: | 14.04.2022 | Language: | EN | [2022/15] | Type: | A1 Application with search report | No.: | EP4225311 | Date: | 16.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.04.2022 takes the place of the publication of the European patent application. | [2023/33] | Search report(s) | International search report - published on: | IL | 14.04.2022 | Classification | IPC: | A61K31/4745, A61P17/06, A61P17/10, A61P17/00, A61P29/00, A61P35/00 | [2023/33] | CPC: |
A61P17/00 (EP,IL);
A61K31/4745 (EP,IL,US);
A61K9/0014 (US);
A61P17/06 (EP,IL,US);
A61P17/10 (EP,IL);
A61P29/00 (EP,IL,US);
A61P35/00 (EP,IL)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/33] | Title | German: | BEHANDLUNG VON HAUTERKRANKUNGEN | [2023/33] | English: | TREATMENT OF SKIN DISEASES | [2023/33] | French: | TRAITEMENT DE MALADIES DE LA PEAU | [2023/33] | Entry into regional phase | 05.05.2023 | National basic fee paid | 05.05.2023 | Search fee paid | 05.05.2023 | Designation fee(s) paid | 05.05.2023 | Examination fee paid | Examination procedure | 05.05.2023 | Amendment by applicant (claims and/or description) | 05.05.2023 | Examination requested [2023/33] | Fees paid | Renewal fee | 25.10.2023 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2005007129 (ANGIOTECH INT AG [CH], et al) [X] 1-20 * Abstract; page 5 lines 10-12; page 35 line 16 to page 36 line 14; claims 1, 38-43, and 50-54. *; | [YX] - L. XI-RAN ET AL., "Topical camptothecine in treatment of psoriasis", (19880101), vol. 27, no. 7, pages 475 - 476, XP002210951 [Y] 1-20 * The whole document. * [X] 1,2,6-20 | [YX] - C. CHING-JUNG ET AL., "Effect of topical use of camptothecine-dimethyl sulfoxide solution in psoriasis", (19750101), vol. 1, no. 5, pages 355 - 360, XP002210950 [Y] 1-20 * The whole document. * [X] 1,2,6-20 | [YX] - Lin Xi-Ran, Huang Tian, Yang Chun-Mei, Tu Cai-Xia, Yang Guo-Ling, "Clinical trial and experimental study on treating psoriasis with camptothecine", Chinese medical journal, (19881231), vol. 101, no. 6, doi:10.5555/cmj.0366-6999.101.06.p427.01, pages 427 - 430, XP055919194 [Y] 1-20 * The whole document. * [X] 1,2,6-20 DOI: http://dx.doi.org/10.5555/cmj.0366-6999.101.06.p427.01 | [YX] - Venâncio João Hélio, Andrade Lígia Marquez, Esteves Najla Locatelli Santos, Brito Lara Barroso, Valadares Marize Campos, Oliveira Gisele Augusto Rodrigues, Lima Eliana Martins, Marreto Ricardo Neves, Gratieri Tais, Taveira Stephânia Fleury, "Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers", Journal of pharmacy and pharmacology : JPP, John Wiley & Sons Ltd, London, GB, GB , (20170905), vol. 69, no. 10, doi:10.1111/jphp.12772, ISSN 0022-3573, pages 1318 - 1326, XP055919198 [Y] 1-20 * Abstract. * [X] 1,3,6,7,12,16-20 DOI: http://dx.doi.org/10.1111/jphp.12772 | [YX] - Daud Adil, Munster Pamela, Hausheer Frederick, Apptec Wuxi, Sullivan Daniel M, "Drug discovery View project HDL Modulation View project", Clinical cancer research, doi:10.1158/1078-0432.CCR-04-1722·Source:, (20050415), Clinical cancer research, URL: https://www.researchgate.net/profile/Frederick-Hausheer/publication/7899014_Phase_II_Trial_of_Karenitecin_in_Patients_with_Malignant_Melanoma_Clinical_and_Translational_Study/links/5908e1cba6fdcc496167935d/Phase-II-Trial-of-Karenitecin-in-Patients-with-Malignant-Melanoma-Clinical-and-Translational-Study.pdf, XP055919200 [Y] 1-20 * Abstract, table 1, and page 3013. * [X] 1,4,7,12 DOI: http://dx.doi.org/10.1158/1078-0432.CCR-04-1722·Source: | [YX] - Galatage Sunil T., Hebalkar Aditya S., Gote Raviraj V., Mali Omkar R., Killedar Suresh G., Bhagwat Durgacharan A., Kumbhar Vijay M., "Design and characterization of camptothecin gel for treatment of epidermoid carcinoma", Future Journal of Pharmaceutical Sciences, (20201201), vol. 6, no. 1, doi:10.1186/s43094-020-00066-6, XP055919202 [Y] 1-20 * Abstract. * [X] 1,2,6,7,12,16-20 DOI: http://dx.doi.org/10.1186/s43094-020-00066-6 | [YX] - O'REILLY S., ROWINSKY E.K., "THE CLINICAL STATUS OF IRINOTECAN (CPT-11), A NOVEL WATER SOLUBLE CAMPTOTHECIN ANALOGUE: 1996.", CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, (19990312), vol. 24, no. 1, pages 47 - 70, XP000922639 [Y] 1-20 * Figure 4 (page 50), table 5 (page 57) and page 61. * [X] 1,4-7,12 | [Y] - Rossi Sharyn L.; Lumpkin Casey J.; Harris Ashlee W.; Holbrook Jennifer; Gentillon Cinsley; McCahan Suzanne M.; Wang Wenlan; Butchbach Matthew E.R., "Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons", Biochemical and Biophysical Research Communications, Elsevier, Amsterdam NL, Amsterdam NL , (20160915), vol. 479, no. 2, doi:10.1016/j.bbrc.2016.09.068, ISSN 0006-291X, pages 319 - 324, XP029755016 [Y] 8 * Abstract. * DOI: http://dx.doi.org/10.1016/j.bbrc.2016.09.068 | [X] - Sun Jun, Dou Wei, Zhao Yi, Hu Jinhong, "A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model", Immunopharmacology and Immunotoxicology, US , (20140201), vol. 36, no. 1, doi:10.3109/08923973.2013.862542, ISSN 0892-3973, pages 17 - 24, XP009535542 [X] 17,19,20 * Abstract. * DOI: http://dx.doi.org/10.3109/08923973.2013.862542 | [A] - Sun Jun, Han Jinzhao, Zhu Quangang, Li Zhen, Hu Jinhong, "Camptothecin Fails to Induce Apoptosis in Tumor Necrosis Factor-Alpha-Treated HaCaT Cells", Pharmacology, CH , (20120301), vol. 89, no. 1-2, doi:10.1159/000335370, ISSN 0031-7012, pages 58 - 63, XP009535541 [A] 1-20 DOI: http://dx.doi.org/10.1159/000335370 |